Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine
Alicia G. Lydecker, Abhisheak Sharma, Christopher R. McCurdy, et al.
Journal of Medical Toxicology (2016) Vol. 12, Iss. 4, pp. 341-349
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel, Oliver Grundmann
Neuropharmacology (2017) Vol. 134, pp. 108-120
Closed Access | Times Cited: 187
Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 138
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7‐hydroxymitragynine
Scott E. Hemby, Scot McIntosh, Francisco León, et al.
Addiction Biology (2018) Vol. 24, Iss. 5, pp. 874-885
Closed Access | Times Cited: 128
Kratom exposures reported to United States poison control centers: 2011–2017
Sara Post, Henry A. Spiller, Thitphalak Chounthirath, et al.
Clinical Toxicology (2019) Vol. 57, Iss. 10, pp. 847-854
Closed Access | Times Cited: 125
Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program
Kirsten E. Smith, Thomas Lawson
Drug and Alcohol Dependence (2017) Vol. 180, pp. 340-348
Closed Access | Times Cited: 116
Current regulatory guidelines and resources to support research of dietary supplements in the United States
Regan L Bailey
Critical Reviews in Food Science and Nutrition (2018) Vol. 60, Iss. 2, pp. 298-309
Open Access | Times Cited: 115
Kratom policy: The challenge of balancing therapeutic potential with public safety
Walter C. Prozialeck, Bonnie A. Avery, Edward W. Boyer, et al.
International Journal of Drug Policy (2019) Vol. 70, pp. 70-77
Open Access | Times Cited: 92
Harnessing the Chemistry of the Indole Heterocycle to Drive Discoveries in Biology and Medicine
Verrill M. Norwood, Robert W. Huigens
ChemBioChem (2019) Vol. 20, Iss. 18, pp. 2273-2297
Closed Access | Times Cited: 88
Characteristics of deaths associated with kratom use
John Corkery, Peter Streete, Hugh Claridge, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1102-1123
Open Access | Times Cited: 84
Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra‐performance liquid chromatography−tandem mass spectrometry
Abhisheak Sharma, Shyam H. Kamble, Francisco León, et al.
Drug Testing and Analysis (2019) Vol. 11, Iss. 8, pp. 1162-1171
Open Access | Times Cited: 82
Kratom Use and Toxicities in the United States
William Eggleston, Robert Stoppacher, Kyle Suen, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2019) Vol. 39, Iss. 7, pp. 775-777
Closed Access | Times Cited: 81
Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users
Darshan Singh, Nelson Jeng‐Yeou Chear, Suresh Narayanan, et al.
Journal of Ethnopharmacology (2019) Vol. 249, pp. 112462-112462
Closed Access | Times Cited: 79
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study
Kirsten E. Smith, Jeffrey M. Rogers, Abhisheak Sharma, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 2, pp. 144-152
Closed Access | Times Cited: 12
Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity
Michael S. Toce, Peter R. Chai, Michele M. Burns, et al.
Journal of Medical Toxicology (2018) Vol. 14, Iss. 4, pp. 306-322
Open Access | Times Cited: 78
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
Shyam H. Kamble, Abhisheak Sharma, Tamara I. King, et al.
Toxicology Letters (2019) Vol. 319, pp. 148-154
Open Access | Times Cited: 61
Evaluating kratom alkaloids using PHASE
Christopher R. Ellis, Rebecca Racz, Naomi L. Kruhlak, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0229646-e0229646
Open Access | Times Cited: 53
Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence
Lisa Wilson, Hannah M. Harris, Shainnel O. Eans, et al.
Drug and Alcohol Dependence (2020) Vol. 216, pp. 108310-108310
Closed Access | Times Cited: 52
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation
Oliver Grundmann, Charles A. Veltri, Diana Morcos, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 4, pp. 433-444
Closed Access | Times Cited: 31
Examining the paradoxical effects of kratom: a narrative inquiry
Kirsten E. Smith, Jeffrey D. Feldman, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia
Darshan Singh, Christian P. Müller, Vikneswaran Murugaiyah, et al.
Journal of Ethnopharmacology (2017) Vol. 214, pp. 197-206
Closed Access | Times Cited: 59
Pharmacologic and clinical assessment of kratom
C Michael White
American Journal of Health-System Pharmacy (2017) Vol. 75, Iss. 5, pp. 261-267
Closed Access | Times Cited: 57
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Zurina Hassan, Oliver G. Bosch, Darshan Singh, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 52
Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats
Bonnie A. Avery, Sai H. S. Boddu, Abhisheak Sharma, et al.
Planta Medica (2018) Vol. 85, Iss. 04, pp. 340-346
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top